依普利酮价格是多少？

Developed by Pfizer of the United States under the trade name Inspra, it was first launched in the United States in 2002. Eplerenone (INSPRA) has definite efficacy in the treatment of hypertension, heart failure and myocardial infarction, has fewer adverse reactions and is well tolerated. Eplerenone has a protective effect on the liver, heart disease, and kidneys without damaging the organs. This drug can promote urination without losing potassium.

How much does eplerenone cost? Eplerenone is available in many countries, and the price varies in different countries:

Price of eplerenone in the United States: Eplerenone marketed in the United States is produced by Pfizer Ltd./Pfizer Pharmaceuticals of the United States. It has two specifications, and the prices are different according to different rules: Pharmacy specification 1: 25mg-30 tablets/box, price: $118.71/USD; Pharmacy specification 2: 50mg-30 tablets/bottle/box, price: $124.09/USD.

Eplerenone price in Russia: Eplerenone marketed in Russia is produced by Pfizer Ltd./Pfizer Pharmaceuticals of the United States. Pharmaceutical specification 1: 25mg-30 tablets/box, price: 3 169.21 руб/unit: Russian rubles; pharmaceutical specification 2: 50mg-30 tablets/box/box, price: 2 984,50 руб/unit: Russian rubles.

Price of eplerenone in India: Eplerenone marketed in India is produced by Lupine Pharmaceuticals of India. Pharmaceutical specification 1: 25mg-15 tablets/box, price: MRP286.5/unit: Indian rupees; pharmaceutical specification 2: 50mg-10 tablets/box/box, price: MRP356.6/unit: Indian rupees. Specification 3: 50mg-100 tablets/box is equivalent to about RMB 500$.

It can be seen that the price in India is the most affordable. At present, eplerenone in India has not been launched in China, so patients can go to India to buy it in person or through domestic overseas medical service institutions.